A new test detecting fetal DNA in a mother?s blood could reduce invasive procedures, such as amniocentesis and removal of tissue from the uterus, to predict birth defects.
In “A Non-invasive Test for Prenatal Diagnosis Based on Fetal DNA Present in Maternal Blood: A Preliminary Study,” published in The Lancet online, Johns Hopkins School of Nursing student Kara Franz and colleagues describe their work isolating fetal DNA to diagnose chromosomal abnormalities.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.